These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 2221710
1. Branch retinal vein occlusion: the pathogenetic role of blood viscosity. Piermarocchi S, Segato T, Bertoja H, Midena E, Zucchetto M, Girolami A, Procidano M, Mares M. Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710 [Abstract] [Full Text] [Related]
6. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion]. Glacet-Bernard A, Coscas G, Lelong F, Chabanel A, Samama M, Taccoen A. Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113 [Abstract] [Full Text] [Related]
17. High prevalence of resistance to APC in young patients with retinal vein occlusion. Kuhli C, Hattenbach LO, Scharrer I, Koch F, Ohrloff C. Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272 [Abstract] [Full Text] [Related]
18. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Lip PL, Blann AD, Jones AF, Lip GY. Eye (Lond); 1998 Mar; 12 ( Pt 2)():245-51. PubMed ID: 9683948 [Abstract] [Full Text] [Related]
19. [Retinal vein occlusion and lipoprotein (a)]. Ribeaudeau-Saindelle F, Glacet-Bernard A, Lelong F, Coscas G, Soubrane G. J Fr Ophtalmol; 1998 Apr; 21(4):245-50. PubMed ID: 9759412 [Abstract] [Full Text] [Related]